Drug Shortage Report for MINT-CITALOPRAM

Last updated on 2023-01-03 History
Report ID 121276
Drug Identification Number 02429705
Brand name MINT-CITALOPRAM
Common or Proper name Citalopram
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CITALOPRAM
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 count Blisters
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-07-27
Actual start date
Estimated end date 2023-02-28
Actual end date
Shortage status Actual shortage
Updated date 2023-01-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-07-28 English Compare
v2 2020-07-28 French Compare
v3 2020-12-07 English Compare
v4 2020-12-07 French Compare
v5 2020-12-07 English Compare
v6 2020-12-07 French Compare
v7 2021-01-11 English Compare
v8 2021-01-11 French Compare
v9 2021-07-12 English Compare
v10 2021-07-12 French Compare
v11 2021-08-10 English Compare
v12 2021-08-10 French Compare
v13 2022-06-06 English Compare
v14 2022-06-06 French Compare
v15 2022-10-31 English Compare
v16 2023-01-03 English Compare
v17 2023-01-03 French Compare

Showing 1 to 17 of 17